| Onco-functional outcome after resection for eloquent glioblastoma (GLIOFO): A propensity-score matched analysis of an international, multicentre, cohort study. JKW Gerritsen, R Mekary, D Pisică, RH Zwarthoed, JL Kilgallon, ... Journal of Clinical Oncology 42 (16_suppl), e14017-e14017, 2024 | | 2024 |
| Towards clinical implementation of an AI-algorithm for detection of cervical spine fractures on computed tomography HC Ruitenbeek, EHG Oei, BL Schmahl, EM Bos, RJCG Verdonschot, ... European Journal of Radiology 173, 111375, 2024 | | 2024 |
| 232 Onco-functional Outcome After Resection for Eloquent Glioblastoma (GLIOFO): A Propensity-score Matched Analysis of an International, Multicenter, Cohort Study J Gerritsen, R Mekary, D Pisica, R Zwarthoed, J Kilgallon, NLA Nawabi, ... Neurosurgery 70 (Supplement_1), 63, 2024 | | 2024 |
| MRI-Based Assessment of Brain Tumor Hypoxia: Correlation with Histology F Arzanforoosh, M Van der Velden, AJL Berman, SR Van der Voort, ... Cancers 16 (1), 138, 2023 | 1 | 2023 |
| Preoperative assessment of eloquence in neurosurgery: a systematic review E Rammeloo, JW Schouten, K Krikour, EM Bos, MS Berger, BV Nahed, ... Journal of Neuro-Oncology 165 (3), 413-430, 2023 | 1 | 2023 |
| Human brain mapping using co-registered fUS, fMRI and ESM during awake brain surgeries: A proof-of-concept study S Soloukey, E Collée, L Verhoef, DD Satoer, CMF Dirven, EM Bos, ... NeuroImage 283, 120435, 2023 | 2 | 2023 |
| SURG-18. ONCO-FUNCTIONAL OUTCOME AFTER RESECTION FOR ELOQUENT GLIOBLASTOMA (GLIOFO STUDY): A PROPENSITY-SCORED ANALYSIS OF AN INTERNATIONAL, MULTICENTER COHORT STUDY J Gerritsen, R Mekary, D Pisica, R Zwarthoed, J Kilgallon, N Nawabi, ... Neuro-Oncology 25 (Supplement_5), v265-v265, 2023 | | 2023 |
| Epidemiology of adult meningioma: report from the Dutch brain tumour registry (2000–2019) VKY Ho, MM Anten, A Garst, EM Bos, TJ Snijders, DBP Eekers, T Seute, ... European Journal of Neurology 30 (10), 3244-3255, 2023 | 3 | 2023 |
| P11. 83. B ONCO-FUNCTIONAL OUTCOME (OFO) AFTER RESECTION FOR ELOQUENT GLIOBLASTOMA (GLIOFO STUDY): A PROPENSITY-SCORED ANALYSIS OF AN INTERNATIONAL, MULTICENTER COHORT STUDY JKW Gerritsen, RA Mekary, D Pisica, RH Zwarthoed, JL Kilgallon, ... Neuro-Oncology 25 (Supplement_2), ii95-ii95, 2023 | | 2023 |
| Local delivery of hrBMP4 as an anticancer therapy in patients with recurrent glioblastoma: a first-in-human phase 1 dose escalation trial EM Bos, E Binda, ISC Verploegh, E Wembacher, D Hoefnagel, ... Molecular cancer 22 (1), 129, 2023 | 9 | 2023 |
| Impact of maximal extent of resection on postoperative deficits, patient functioning, and survival within clinically important glioblastoma subgroups JKW Gerritsen, RH Zwarthoed, JL Kilgallon, NL Nawabi, G Versyck, ... Neuro-oncology 25 (5), 958-972, 2023 | 14 | 2023 |
| 883 Impact of Awake Craniotomy within Eloquent Glioblastoma Subgroups (GLIOMAP): A Propensity-Score Matched Analysis of an International, Multicenter, Cohort Study J Gerritsen, R Zwarthoed, J Kilgallon, N Nawabi, C Jessurun, G Versyck, ... Neurosurgery 69 (Supplement_1), 50, 2023 | | 2023 |
| Efficacy and safety of peptide receptor radionuclide therapy with [177Lu] Lu-DOTA-TATE in 15 patients with progressive treatment-refractory meningioma NS Minczeles, EM Bos, RC de Leeuw, JM Kros, MW Konijnenberg, ... European Journal of Nuclear Medicine and Molecular Imaging 50 (4), 1195-1204, 2023 | 12 | 2023 |
| Neuro-Oncology Advances KT Quach, L Dirven, AM Vingerhoed, J de Bresser, R Dammers, EM Bos, ... | | 2023 |
| The prevalence and severity of fatigue in meningioma patients and its association with patient-, tumor-and treatment-related factors KT Quach, L Dirven, AM Vingerhoed, J de Bresser, R Dammers, EM Bos, ... Neuro-Oncology Advances 5 (1), vdad056, 2023 | | 2023 |
| Reconstructing human cerebral vasculature in 3D with high frame rate, freehand 2D Doppler ultrasound using optical tracking L Verhoef, S Soloukey, F Mastik, BS Generowicz, AJPE Vincent, EM Bos, ... 2022 IEEE International Ultrasonics Symposium (IUS), 1-4, 2022 | | 2022 |
| Intra-arterial Administration of [Ga-68] Ga-PSMA and [Ga-68] Ga-DOTA-TATE in CNS Tumors; a Novel Approach that Highly Increases the Potential Effect of Future Theranostic … IJ Pruis, PJ Van Doormaal, FA Verburg, RK Balvers, EM Bos, ... EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 49 (SUPPL 1), S84-S84, 2022 | | 2022 |
| KS04. 6. A Epidemiology of adult meningioma in the Netherlands: a population-based study VKY Ho, MM Anten, A Garst, EM Bos, TJ Snijders, DBP Eekers, T Seute Neuro-Oncology 24 (Suppl 2), ii5, 2022 | | 2022 |
| P01. 12. B Analysis of semi-spontaneous speech before, during and after awake craniotomy: a case study EC Gommers, KE Collée, A Vincent, EM Bos, CMF Dirven, SK Koekkoek, ... Neuro-Oncology 24 (Supplement_2), ii26-ii26, 2022 | | 2022 |
| Effect of awake craniotomy in glioblastoma in eloquent areas (GLIOMAP): a propensity score-matched analysis of an international, multicentre, cohort study JKW Gerritsen, RH Zwarthoed, JL Kilgallon, NL Nawabi, CAC Jessurun, ... The Lancet Oncology 23 (6), 802-817, 2022 | 39 | 2022 |
Prof.dr. H van GoorDepartment of Pathology and Medical Biology, University Medical Center GroningenVerified email at umcg.nl
